Aaron P. Jansen, Ph.D. - Publications

Affiliations: 
2000 University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Cell Biology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagan JP, Colburn NH. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Research. 68: 1254-60. PMID 18296647 DOI: 10.1158/0008-5472.CAN-07-1719  0.376
2005 Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Research. 65: 6034-41. PMID 16024603 DOI: 10.1158/0008-5472.CAN-04-2119  0.461
2001 Jansen AP, Dreckschmidt NE, Verwiebe EG, Wheeler DL, Oberley TD, Verma AK. Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. International Journal of Cancer. 93: 635-43. PMID 11477572 DOI: 10.1002/Ijc.1395  0.522
2001 Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 20: 669-76. PMID 11314000 DOI: 10.1038/Sj.Onc.1204137  0.527
2001 Jansen AP, Verwiebe EG, Dreckschmidt NE, Wheeler DL, Oberley TD, Verma AK. Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Research. 61: 808-12. PMID 11221859  0.535
1999 Jansen AP, Colburn NH, Verma AK. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation. Oncogene. 18: 5806-13. PMID 10523861 DOI: 10.1038/Sj.Onc.1202965  0.558
Show low-probability matches.